Art

J-GLOBAL ID：201702244390742414   Reference number：17A0359913

Transient symptomatic worsening by atropine in opsoclonus-myoclonus syndrome

オプソクローヌス・ミオクローヌス症候群におけるアトロピンによる一過性の症状悪化

Author (7)： Miyoshi Hirotsugu (Department of Anesthesiology and Critical Care, Hiroshima University Hospital, Hiroshima, Japan) ,  Nakamura Ryuji (Department of Anesthesiology and Critical Care, Hiroshima University Hospital, Hiroshima, Japan) ,  Yamaga Ayano (Department of Anesthesiology and Critical Care, Hiroshima University Hospital, Hiroshima, Japan) ,  Haraki Toshiaki (Department of Anesthesiology and Critical Care, Hiroshima University Hospital, Hiroshima, Japan) ,  Yasuda Toshimichi (Department of Anesthesiology and Critical Care, Hiroshima University Hospital, Hiroshima, Japan) ,  Hamada Hiroshi (Department of Anesthesiology and Critical Care, Hiroshima University Hospital, Hiroshima, Japan) ,  Kawamoto Masashi (Department of Anesthesiology and Critical Care, Hiroshima University Hospital, Hiroshima, Japan)
Material： Pediatrics International (Web)  (Pediatr Int (Web))
Volume： 59  Issue： 1  Page： 97-98  Publication year： 2017 
JST Material Number： U0706A  ISSN： 1442-200X  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： *ocular motility disorder ,...
Semi thesaurus term： *Opsoclonus-Myoclonus Syndrome ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0359913&from=J-GLOBAL&jstjournalNo=U0706A") }}

Author keywords (3)： anticholinergic syndrome ,  atropine ,  opsoclonus-myoclonus syndrome

JST classification (3)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Drug therapy(=pharmacotherapy)for eye diseases  (GP05020E) ,  Basic research of drugs acting on sensory organs  (GW04060K)

Substance index (3)： Atropine ,  Midazolam ,  Thiamylal

Reference (9)：

• Pinsard N, Pons-Cerdan C, Mancini J, Livet MO, Bernard R. Ataxia-opsoclonus-myoclonus syndrome. Sem. Hop. 1981; 57: 488-94.
• Stephenson JB, Graham-Pole J, Ogg L, Cochran AJ. Reactivity to neuroblastoma extracts in childhood cerebellar encephalopathy (“dancing eyes” syndrome). Lancet 1976; 2: 975-6.
• Tate ED, Pranzatelli MR, Huang Y. An innovative approach to the problem of sedating children with opsoclonus-myoclonus syndrome: effects of myoclonus and CSF monoamine metabolites. Ann. Neurol. 1994; 36: 543-4.
• Pranzatelli MR. Opsoclonus-myoclonus-ataxia syndrome. In: Emilio FA, Alexis A, Eduardo T (eds). Paediatric Movement Disorders: Progress in Understanding. John Libey Eurotext, Montrouge, 2005; 121-35.
• Burrows FA, Seeman RG. Ketamine and myoclonic encephalopathy of infants (Kinsbourne syndrome). Anesth. Analg. 1982; 61: 873-5.

Terms in the title (5)： オプソクローヌス ,  ミオクローヌス症候群 ,  アトロピン ,  症状 ,  悪化